InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,518.00
(
0.53%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
70.96
(
-3.05%
)
Bitcoin
63,721.11
(
0.93%
)
Post# of 294600
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

PSY

Send PM Follow Ignore
Followers 74
Posts 11509
Boards Moderated 0
Alias Born 04/24/2012

PSY

Re: None

Friday, 11/15/2019 12:47:21 PM

Friday, November 15, 2019 12:47:21 PM

Post# of 294600
$RXMD Third Quarter 2019 Financial Highlights

Consolidated quarterly year-over-year Revenue Growth of 91% to $10.14 million
Q3 Gross Margins expanded to 24.4% (versus Q2 22.7%, Q1 19.8%)
Gross Profit up 128% year-over-year to $2.47 million
Prescriptions Filled up 52% to 323k for nine months ended Sep. 30 (vs 2018 comparable period)
Prescriptions Filled up 70% to 136k in Q3, on quarterly year-over-year basis
Cash level up 774% year-to-date to $759,016
Accounts Receivable up 96% year-to-date to $2,372,177
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up